TORONTO, Nov. 25, 2024 /CNW/ - CareRx Corporation ("CareRx" or "the Company") (TSX: CRRX) today announced that the final tranche of the unsecured convertible debentures (the "Convertible Debentures") originally issued by the Company on November 22, 2019, have been converted into common shares ("Common Shares") at a price of C$3.00 per Common Share pursuant to the terms of the Convertible Debentures.
Read more at newswire.caCareRx Announces Final Conversion of Convertible Debentures
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.